Scroll To Top
Health

Industry report: 83 new HIV/AIDS treatments in development


We need your help
Your support makes The Advocate's original LGBTQ+ reporting possible. Become a member today to help us continue this work.

A report released Thursday by the Pharmaceutical Research and Manufacturers of America, a drug industry trade group, shows that there are 83 new HIV/AIDS-related treatments currently in the development pipeline at U.S. and international drug companies. Among the compounds are 14 HIV vaccines and 33 antiretroviral drugs as well as a number of compounds to treat AIDS-related complications. All of the treatments are in human trials or are awaiting Food and Drug Administration approval. According to the report, titled "New Medicines in Development for AIDS," a total of 74 drugs have been approved to treat HIV disease and AIDS-related complications since 1987. "We now have a large number of medicines in development to attack HIV in a variety of ways," PhRMA senior vice president John Kelly told Dow Jones Business News. "We've made tremendous progress, but we have more to do."

Recommended Stories for You

Pride of Broadway Special

From our Sponsors

Most Popular

Latest Stories